Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerie Albrecht

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Oncotarget|June 4, 2016
A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancerLinda Kinzel, Anne Ernst, Michael Orth, et al.
Microbial Genomics|November 21, 2023
Comparison of carbapenem-susceptible and carbapenem-resistant <i>Enterobacterales</i> at nine sites in the USA, 2013-2016: a resource for antimicrobial resistance investigatorsJoseph D Lutgring, Alyssa G Kent, Jolene R Bowers, et al.
Frontiers in Microbiology|February 18, 2022
Sentinel Surveillance Reveals Emerging Daptomycin-Resistant ST736 <i>Enterococcus faecium</i> and Multiple Mechanisms of Linezolid Resistance in Enterococci in the United StatesAmy S Gargis, Lori M Spicer, Alyssa G Kent, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2022
Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17Amy S Gargis, Maria Karlsson, Ashley L Paulick, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|February 16, 2022
Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United StatesMaria Karlsson, Joseph D Lutgring, Uzma Ansari, et al.
Emerging Infectious Diseases|June 19, 2019
Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015Maroya Spalding Walters, Julian E Grass, Sandra N Bulens, et al.
American Journal of Infection Control|July 31, 2022
Carbapenem-Resistant enterobacterales in individuals with and without health care risk factors -Emerging infections program, United States, 2012-2015Sandra N Bulens, Hannah E Reses, Uzma A Ansari, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Oncotarget|June 4, 2016
A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancerLinda Kinzel, Anne Ernst, Michael Orth, et al.
Microbial Genomics|November 21, 2023
Comparison of carbapenem-susceptible and carbapenem-resistant <i>Enterobacterales</i> at nine sites in the USA, 2013-2016: a resource for antimicrobial resistance investigatorsJoseph D Lutgring, Alyssa G Kent, Jolene R Bowers, et al.
Frontiers in Microbiology|February 18, 2022
Sentinel Surveillance Reveals Emerging Daptomycin-Resistant ST736 <i>Enterococcus faecium</i> and Multiple Mechanisms of Linezolid Resistance in Enterococci in the United StatesAmy S Gargis, Lori M Spicer, Alyssa G Kent, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2022
Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17Amy S Gargis, Maria Karlsson, Ashley L Paulick, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|February 16, 2022
Molecular Characterization of Carbapenem-Resistant Enterobacterales Collected in the United StatesMaria Karlsson, Joseph D Lutgring, Uzma Ansari, et al.
Emerging Infectious Diseases|June 19, 2019
Carbapenem-Resistant Pseudomonas aeruginosa at US Emerging Infections Program Sites, 2015Maroya Spalding Walters, Julian E Grass, Sandra N Bulens, et al.
American Journal of Infection Control|July 31, 2022
Carbapenem-Resistant enterobacterales in individuals with and without health care risk factors -Emerging infections program, United States, 2012-2015Sandra N Bulens, Hannah E Reses, Uzma A Ansari, et al.
Pageof 3